Veterinary Medicines

Nobilis Reo Inac Emulsie voor injectie

Authorised
  • Avian reovirus, strain 2408, Inactivated
  • Avian reovirus, strain 1733, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis Reo Inac Emulsie voor injectie
Nobilis Reo Inac Emulsion injectable
Nobilis Reo Inac Emulsion zur Injektion
Active substance:
  • Avian reovirus, strain 2408, Inactivated
  • Avian reovirus, strain 1733, Inactivated
Target species:
  • Chicken (for reproduction)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Avian reovirus, strain 2408, Inactivated
    7.40
    enzyme-linked immunosorbent assay unit
    /
    0.50
    millilitre(s)
  • Avian reovirus, strain 1733, Inactivated
    7.40
    enzyme-linked immunosorbent assay unit
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (for reproduction)
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
  • Subcutaneous use
    • Chicken (for reproduction)
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Nobilis Reo Inac 1 glass Vial with 1000 doses of Emulsion for injection
  • Nobilis Reo Inac 1 glass Vial with 500 doses of Emulsion for injection
  • Nobilis Reo Inac 1 PET Vial with 1000 doses of Emulsion for injection
  • Nobilis Reo Inac 1 PET Vial with 500 doses of Emulsion for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/04/2024
Download
French (PDF)
Published on: 17/04/2024
Download
German (PDF)
Published on: 17/04/2024
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/04/2024
Download
French (PDF)
Published on: 17/04/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/04/2024
Download
French (PDF)
Published on: 17/04/2024
Download
German (PDF)
Published on: 17/04/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."